Prețul Paladiului

Founded by Chicago physician Wallace Calvin Abbott in 1888 and listed since 1929, Abbott Laboratories (ABT.US), is a global healthcare leader dedicated to enhancing people's lives through the development of diversified healthcare products and technologies. With a longstanding commitment to research and innovation.

Abbott provides an array of solutions spanning nutrition, diagnostics, medical devices, and branded generic pharmaceuticals. Headquartered in Abbott Park, Illinois, the company has 115,000 employees and operates in over 160 countries, consistently striving to make a lasting impact by addressing some of the world's most pressing health challenges.

As of August 2023, its market capitalization is 182.73B USD.

Abbott Laboratories has stood as a cornerstone in the healthcare sector, with its stock reflecting both the company's internal achievements and the broader economic tides.

Throughout the mid-2010s, Abbott's stock benefited from a series of successful acquisitions and product launches. The approval and success of the FreeStyle Libre glucose monitoring system was a particular highlight, marking Abbott's prowess in the medical devices sector. Over recent years their share price has varied from a low of $64.03 in 2018 to an ATH of $140.74 in 2021.

​Abbott Laboratories, given its diversified product range across healthcare, faces competition from several prominent companies in various sectors.

Some primary competitors include Johnson & Johnson, Becton Dickinson, Nestlé, and Danone. Abbott's comprehensive product portfolio means that it faces competition across multiple fronts, but it also gives the company a diversified revenue stream.